OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹40 Cr | ₹31 Cr | ₹6,052,481 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹40 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹6,052,481 Cr |
| Mar2022 | ₹52 Cr |
| Mar2021 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | 27.93 | |
| Mar2024 | ₹31 Cr | -100.00 | |
| Mar2023 | ₹6,052,481 Cr | 11,633,245.46 | |
| Mar2022 | ₹52 Cr | 279.32 | |
| Mar2021 | ₹14 Cr | - | |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹185.4 Cr | -0.9% | -14.4% | -29.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -0.9% |
-14.4% |
-29.1% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses